Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA Mechanism of Action in Colorectal Cancer Prevention
NCT02125409Phase 3Unknown
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in colorectal cancer (CRC), sponsored by Instituto Aragonés de Ciencias de la Salud. Status: unknown.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02125409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125409.